Immunomodulation of NK Cells by Ionizing Radiation
- PMID: 32612950
- PMCID: PMC7308459
- DOI: 10.3389/fonc.2020.00874
Immunomodulation of NK Cells by Ionizing Radiation
Abstract
Natural killer (NK) cells play a critical role in the antitumor immunity. Ionizing radiation (IR) has a pronounced effect on modifying NK cell biology, while the molecular mechanisms remain elusive. In this review, we briefly introduce the anti-tumor activity of NK cells and summarize the impact of IR on NK cells both directly and indirectly. On one hand, low-dose ionizing radiation (LDIR) activates NK functions while high-dose ionizing radiation (HDIR) is likely to partially impair NK functions, which can be reversed by interleukin (IL)-2 pretreatment. On the other hand, NK functions may be adjusted by other immune cells and the alternated malignant cell immunogenicity under the settings of IR. Various immune cells, such as the tumor-associated macrophage (TAM), dendritic cell (DC), regulatory T cell (Treg), myeloid-derived suppressor cell (MDSC), and tumor exhibited ligands, such as the natural killer group 2 member D ligand (NKG2DL), natural cytotoxicity receptors (NCR) ligand, TNF-related apoptosis-inducing ligand-receptor (TRAIL-R), and FAS, have been involved in this process. Better understanding the molecular basis is a promising way in which to augment NK-cell-based antitumor immunity in combination with IR.
Keywords: NK cell; immune response; immunotherapy; ionizing radiation; tumor.
Copyright © 2020 Chen, Liu, Zeng, Li, Luo, Sun, Gong, Zhang, Wu and Xie.
Figures
Similar articles
-
Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy.Cancer Biother Radiopharm. 2014 Dec;29(10):428-34. doi: 10.1089/cbr.2014.1702. Cancer Biother Radiopharm. 2014. PMID: 25402754 Free PMC article.
-
Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.J Leukoc Biol. 2005 Aug;78(2):359-71. doi: 10.1189/jlb.0604360. Epub 2005 Jun 3. J Leukoc Biol. 2005. PMID: 15937142
-
Clinically feasible approaches to potentiating cancer cell-based immunotherapies.Hum Vaccin Immunother. 2015;11(4):851-69. doi: 10.1080/21645515.2015.1009814. Hum Vaccin Immunother. 2015. PMID: 25933181 Free PMC article. Review.
-
Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.J Immunol. 2005 Mar 1;174(5):2653-60. doi: 10.4049/jimmunol.174.5.2653. J Immunol. 2005. PMID: 15728472
-
Natural killer group 2D receptor and its ligands in cancer immune escape.Mol Cancer. 2019 Feb 27;18(1):29. doi: 10.1186/s12943-019-0956-8. Mol Cancer. 2019. PMID: 30813924 Free PMC article. Review.
Cited by
-
Tumor accomplice: T cell exhaustion induced by chronic inflammation.Front Immunol. 2022 Sep 2;13:979116. doi: 10.3389/fimmu.2022.979116. eCollection 2022. Front Immunol. 2022. PMID: 36119037 Free PMC article. Review.
-
Preliminary Study on Natural Killer Cell Activity for Interferon-Gamma Production after Gamma Knife Radiosurgery for Brain Tumors.J Korean Neurosurg Soc. 2022 Nov;65(6):861-867. doi: 10.3340/jkns.2020.0339. Epub 2022 Nov 1. J Korean Neurosurg Soc. 2022. PMID: 36344478 Free PMC article.
-
Dark Side of Cancer Therapy: Cancer Treatment-Induced Cardiopulmonary Inflammation, Fibrosis, and Immune Modulation.Int J Mol Sci. 2021 Sep 19;22(18):10126. doi: 10.3390/ijms221810126. Int J Mol Sci. 2021. PMID: 34576287 Free PMC article. Review.
-
Radiation-induced tumor immune microenvironments and potential targets for combination therapy.Signal Transduct Target Ther. 2023 May 19;8(1):205. doi: 10.1038/s41392-023-01462-z. Signal Transduct Target Ther. 2023. PMID: 37208386 Free PMC article. Review.
-
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma.Front Vet Sci. 2021 Jun 7;8:672361. doi: 10.3389/fvets.2021.672361. eCollection 2021. Front Vet Sci. 2021. PMID: 34164452 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous